Guangxi LiuYao Group Co Ltd
SSE:603368
Intrinsic Value
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the wholesale and retail business of medicines and medical equipment. [ Read More ]
The intrinsic value of one Guangxi LiuYao Group Co Ltd stock under the Base Case scenario is 53.76 CNY. Compared to the current market price of 21.5 CNY, Guangxi LiuYao Group Co Ltd is Undervalued by 60%.
Valuation Backtest
Guangxi LiuYao Group Co Ltd
Run backtest to discover the historical profit from buying and selling Guangxi LiuYao Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Guangxi LiuYao Group Co Ltd
| Current Assets | 18.3B |
| Cash & Short-Term Investments | 3.2B |
| Receivables | 11.9B |
| Other Current Assets | 3.2B |
| Non-Current Assets | 2.4B |
| Long-Term Investments | 5.8m |
| PP&E | 1.2B |
| Intangibles | 1B |
| Other Non-Current Assets | 193.3m |
| Current Liabilities | 12.4B |
| Accounts Payable | 3.6B |
| Accrued Liabilities | 15.2m |
| Short-Term Debt | 7.7B |
| Other Current Liabilities | 1.2B |
| Non-Current Liabilities | 1.9B |
| Long-Term Debt | 1.1B |
| Other Non-Current Liabilities | 743.7m |
Earnings Waterfall
Guangxi LiuYao Group Co Ltd
|
Revenue
|
20.4B
CNY
|
|
Cost of Revenue
|
-18.1B
CNY
|
|
Gross Profit
|
2.3B
CNY
|
|
Operating Expenses
|
-1.1B
CNY
|
|
Operating Income
|
1.2B
CNY
|
|
Other Expenses
|
-419.2m
CNY
|
|
Net Income
|
800.8m
CNY
|
Free Cash Flow Analysis
Guangxi LiuYao Group Co Ltd
Profitability Score
Profitability Due Diligence
Guangxi LiuYao Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Guangxi LiuYao Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Guangxi LiuYao Group Co Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Guangxi LiuYao Group Co Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Guangxi LiuYao Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Guangxi LiuYao Group Co Ltd is 30.71 CNY with a low forecast of 30.41 CNY and a high forecast of 31.62 CNY.
Shareholder Return
Price
Guangxi LiuYao Group Co Ltd
| Average Annual Return | -3.36% |
| Standard Deviation of Annual Returns | 3.27% |
| Max Drawdown | -48% |
| Market Capitalization | 7.7B CNY |
| Shares Outstanding | 359 777 800 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the wholesale and retail business of medicines and medical equipment. The company is headquartered in Liuzhou, Guangxi and currently employs 4,751 full-time employees. The company went IPO on 2014-12-04. The firm is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and research and development of pharmaceuticals and medical devices. The firm is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services, etc.
Contact
IPO
Employees
Officers
The intrinsic value of one Guangxi LiuYao Group Co Ltd stock under the Base Case scenario is 53.76 CNY.
Compared to the current market price of 21.5 CNY, Guangxi LiuYao Group Co Ltd is Undervalued by 60%.
You don't have any saved screeners yet
